Media coverage about Luna Innovations (NASDAQ:LUNA) has been trending somewhat positive recently, according to Accern. The research group identifies positive and negative news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Luna Innovations earned a news sentiment score of 0.09 on Accern’s scale. Accern also gave news articles about the scientific and technical instruments company an impact score of 46.7098891643212 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Here are some of the media stories that may have effected Accern’s analysis:

NASDAQ LUNA traded up $0.05 during mid-day trading on Friday, hitting $3.95. The stock had a trading volume of 111,178 shares, compared to its average volume of 189,391. Luna Innovations has a twelve month low of $1.34 and a twelve month high of $4.32. The company has a market cap of $106.56 million, a P/E ratio of 48.75 and a beta of 0.91.

Luna Innovations (NASDAQ:LUNA) last issued its earnings results on Wednesday, August 1st. The scientific and technical instruments company reported $0.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.02 by $0.01. Luna Innovations had a return on equity of 4.98% and a net margin of 34.13%. The business had revenue of $13.77 million during the quarter, compared to the consensus estimate of $12.90 million. research analysts predict that Luna Innovations will post 0.07 EPS for the current fiscal year.

Several brokerages have recently weighed in on LUNA. Zacks Investment Research downgraded Luna Innovations from a “strong-buy” rating to a “hold” rating in a research note on Friday, May 11th. Northland Securities downgraded Luna Innovations from an “outperform” rating to a “market perform” rating and set a $4.00 price objective for the company. in a research note on Friday, August 3rd.

In other Luna Innovations news, major shareholder Clinic Carilion sold 102,930 shares of the firm’s stock in a transaction on Friday, May 18th. The stock was sold at an average price of $3.40, for a total value of $349,962.00. Following the completion of the sale, the insider now directly owns 2,162,235 shares of the company’s stock, valued at approximately $7,351,599. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders sold a total of 165,197 shares of company stock valued at $561,798 over the last ninety days. Corporate insiders own 10.60% of the company’s stock.

Luna Innovations Company Profile

Luna Innovations Incorporated develops, manufactures, and markets fiber optic sensing, and test and measurement products worldwide. It operates in two segments, Products and Licensing, and Technology Development. The Products and Licensing segment offers fiber optic sensing products, as well as test and measurement products to monitor the integrity of fiber optic network components and sub-assemblies, which include optical vector analyzer, optical backscatter reflectometers, and the Phoenix family of tunable lasers; and distributed sensing systems comprising optical distributed sensor interrogator sensing solution with multiple sensors whose inputs are integrated through a fiber optic network and software.

Featured Story: Penny Stocks, What You Need To Know

Insider Buying and Selling by Quarter for Luna Innovations (NASDAQ:LUNA)

Receive News & Ratings for Luna Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luna Innovations and related companies with MarketBeat.com's FREE daily email newsletter.